Why QuantumScape Stock Is Rocketing Higher Today
QuantumScape announces an important milestone on the way to commercializing its EV solid-state battery technology.
The company is ahead of schedule to begin field testing by EV manufacturing partners.
QuantumScape stock remains speculative, but investors sense the risk level dropping.
10 stocks we like better than QuantumScape ›
Investors have been speculating on QuantumScape (NYSE: QS) stock and its ability to revolutionize electric vehicle (EV) batteries for several years now. It's been a slow road as the company works toward commercializing its solid-state battery technology.
After the company announced a major milestone, QuantumScape shares shot higher by as much as 47% Wednesday morning. At 10:07 a.m. ET, the stock remained 40.5% higher.
When QuantumScape reported its first-quarter update, on April 23, management said it was ahead of schedule on one of its 2025 goals to bring its next planned phase into baseline production. The "Cobra" phase, which will allow it to scale up manufacturing of its solid-state battery cells, has now become a reality.
In the company's announcement, CEO Dr. Siva Sivaram stated, "By significantly improving throughput and shrinking the equipment footprint, Cobra gives us a powerful path forward for commercializing our next-generation battery technology." Co-founder and chief technology officer (CTO) Tim Holme called the advancement critical to bring its battery production "to market at gigawatt scale."
That's exactly what longtime investors have been waiting to hear from QuantumScape. With the Cobra production platform now in place, QuantumScape plans to launch field testing next year with a baseline production process for the next-generation battery technology.
Solid-state batteries include ceramic separators that should lead to safer, faster-charging, and more efficient solid-state lithium-metal batteries. The practical result could be EV travel range on a single charge that eliminates range anxiety for potential EV consumers.
QuantumScape stock is still a speculative bet. But the risk level drops as the company gets closer to commercialization. The Cobra process was a big step, and investors are rewarding the stock in a big way today.
Before you buy stock in QuantumScape, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and QuantumScape wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $689,813!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $906,556!*
Now, it's worth noting Stock Advisor's total average return is 809% — a market-crushing outperformance compared to 175% for the S&P 500. Don't miss out on the latest top 10 list, available when you join .
See the 10 stocks »
*Stock Advisor returns as of June 23, 2025
Howard Smith has positions in QuantumScape. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.
Why QuantumScape Stock Is Rocketing Higher Today was originally published by The Motley Fool
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Upturn
24 minutes ago
- Business Upturn
Moody's fully acquires ICR Chile, solidifying its leading position in key Latin American markets
New York, United States: Moody's Corporation (NYSE:MCO) announced today that it has fully acquired ICR Chile (ICR), a leading provider of domestic credit ratings in Chile. The transaction follows Moody's 2019 acquisition of a minority stake in ICR and will further strengthen its presence in Latin America's domestic credit markets. Following the transaction, ICR will continue issuing domestic ratings in Chile under its own rating process and methodologies. In the following months, ICR will be fully integrated into Moody's Local, a group of leading credit rating agencies in Latin America. 'Today's acquisition builds on our successful partnership with ICR and underscores our commitment to Chile's growing debt capital market,' said Martin Fernandez-Romero, Managing Director of Moody's Local. 'Bringing ICR into Moody's Local will enhance our ability to provide high quality credit ratings, research, and analytical services to market participants, while contributing to greater transparency in Latin America.' Founded in 2005, ICR is renowned for its high-quality analyses and the expertise of its analytical teams. It provides ratings across a diverse range of sectors, including corporates, financial institutions, insurers, structured finance vehicles, funds, and project finance. Since Moody's initial investment, ICR has gained market growth, driven by its in-depth creditanalyses and the expansion of its coverage within Chile's domestic ratings market. The terms of the transaction were not disclosed, and it will not have a material impact on Moody's 2025 financial results. About Moody's Local Moody's Local is a group of domestic rating agencies covering 13 Latin America's domestic financial markets. Moody's Local provides domestic credit ratings, research and risk analyses to market professionals with methodologies and seasoned analysts that capture the unique risks and dynamics of each market. Learn more at About Moody's Corporation In a world shaped by increasingly interconnected risks, Moody's (NYSE: MCO) data, insights, and innovative technologies help customers develop a holistic view of their world and unlock opportunities. With a rich history of experience in global markets and a diverse workforce of approximately 16,000 across more than 40 countries, Moody's gives customers the comprehensive perspective needed to act with confidence and thrive. Learn more at 'Safe Harbor' statement under the Private Securities Litigation Reform Act of 1995 Certain statements included in this release are forward-looking statements and are based on future expectations, plans and prospects for Moody's business and operations that involve a number of risks and uncertainties. Such statements involve estimates, projections, goals, forecasts, assumptions and uncertainties that could cause actual results or outcomes to differ materially from those contemplated, expressed, projected, anticipated or implied in the forward-looking statements. The forward-looking statements and other information in this document are made as of the date hereof, and Moody's undertakes no obligation (nor does it intend) to publicly supplement, update or revise such statements on a going-forward basis, whether as a result of subsequent developments, changed expectations or otherwise, except as required by applicable law or regulation. In connection with the 'safe harbor' provisions of the Private Securities Litigation Reform Act of 1995, Moody's is identifying certain factors that could cause actual results to differ, perhaps materially, from those indicated by these forward-looking statements. Those factors, risks and uncertainties include, but are not limited to: the uncertain effects of U.S. and foreign government actions affecting international trade and economic policy, including changes and volatility in tariffs and trade policies and retaliatory actions, on credit markets, customers and customer retention, and demand for our products and services; the impact of general economic conditions (including significant government debt and deficit levels, and inflation or recessions and related monetary policy actions by governments in response thereto) on worldwide credit markets and on economic activity, including on the level of merger and acquisition activity, and their effects on the volume of debt and other securities issued in domestic and/or global capital markets; the uncertain effects of U.S. and foreign government initiatives and monetary policy to respond to the current economic climate, including instability of financial institutions, credit quality concerns, and other potential impacts of volatility in financial and credit markets; the impact of geopolitical events and actions, such as the Russia-Ukraine military conflict and military conflict in the Middle East, and of tensions and disputes in political and global relations, on volatility in world financial markets, on general economic conditions and GDP in the U.S. and worldwide and on Moody's own operations and personnel; other matters that could affect the volume of debt and other securities issued in domestic and/or global capital markets, including regulation, increased utilization of technologies that have the potential to intensify competition and accelerate disruption and disintermediation in the financial services industry, as well as the number of issuances of securities without ratings or securities which are rated or evaluated by non-traditional parties; the level of merger and acquisition activity in the U.S. and abroad; the impact of MIS's withdrawal of its credit ratings on countries or entities within countries and of Moody's no longer conducting commercial operations in countries where political instability warrants such actions; concerns in the marketplace affecting our credibility or otherwise affecting market perceptions of the integrity or utility of independent credit agency ratings; the introduction or development of competing and/or emerging technologies and products; pricing pressure from competitors and/or customers; the level of success of new product development and global expansion; the impact of regulation as an NRSRO, the potential for new U.S., state and local legislation and regulations; the potential for increased competition and regulation in the jurisdictions in which we operate, including the EU; exposure to litigation related to our rating opinions, as well as any other litigation, government and regulatory proceedings, investigations and inquiries to which Moody's may be subject from time to time; provisions in U.S. legislation modifying the pleading standards and EU regulations modifying the liability standards applicable to CRAs in a manner adverse to CRAs; provisions of EU regulations imposing additional procedural and substantive requirements on the pricing of services and the expansion of supervisory remit to include non-EU ratings used for regulatory purposes; uncertainty regarding the future relationship between the U.S. and China; the possible loss of key employees and the impact of the global labor environment; failures or malfunctions of our operations and infrastructure; any vulnerabilities to cyber threats or other cybersecurity concerns; the timing and effectiveness of our restructuring programs; currency and foreign exchange volatility; the outcome of any review by tax authorities of Moody's global tax planning initiatives; exposure to potential criminal sanctions or civil remedies if Moody's fails to comply with foreign and U.S. laws and regulations that are applicable in the jurisdictions in which Moody's operates, including data protection and privacy laws, sanctions laws, anti-corruption laws, and local laws prohibiting corrupt payments to government officials; the impact of mergers, acquisitions, or other business combinations and the ability of Moody's to successfully integrate acquired businesses; the level of future cash flows; the levels of capital investments; and a decline in the demand for credit risk management tools by financial institutions, corporate or government entities. These factors, risks and uncertainties as well as other risks and uncertainties that could cause Moody's actual results to differ materially from those contemplated, expressed, projected, anticipated or implied in the forward-looking statements are described in greater detail under 'Risk Factors' in Part I, Item 1A of Moody's annual report on Form 10-K for the year ended December 31, 2024, and in other filings made by the Company from time to time with the SEC or in materials incorporated herein or therein. Stockholders and investors are cautioned that the occurrence of any of these factors, risks and uncertainties may cause the Company's actual results to differ materially from those contemplated, expressed, projected, anticipated or implied in the forward-looking statements, which could have a material and adverse effect on the Company's business, results of operations and financial condition. New factors may emerge from time to time, and it is not possible for the Company to predict new factors, nor can the Company assess the potential effect of any new factors on it. Forward-looking and other statements in this document may also address our corporate responsibility progress, plans, and goals (including sustainability and environmental matters), and the inclusion of such statements is not an indication that these contents are necessarily material to investors or required to be disclosed in the Company's filings with the Securities and Exchange Commission. In addition, historical, current, and forward-looking sustainability-related statements may be based on standards for measuring progress that are still developing, internal controls and processes that continue to evolve, and assumptions that are subject to change in the future. View source version on Disclaimer: The above press release comes to you under an arrangement with Business Wire. Business Upturn takes no editorial responsibility for the same. Ahmedabad Plane Crash
Yahoo
44 minutes ago
- Yahoo
Humacyte, Inc. (HUMA) Stock Moves -1.79%: What You Should Know
In the latest close session, Humacyte, Inc. (HUMA) was down 1.79% at $2.19. Meanwhile, the Dow lost 0.25%, and the Nasdaq, a tech-heavy index, added 0.31%. The company's stock has dropped by 10.08% in the past month, falling short of the Medical sector's gain of 3.46% and the S&P 500's gain of 5.05%. The investment community will be paying close attention to the earnings performance of Humacyte, Inc. in its upcoming release. On that day, Humacyte, Inc. is projected to report earnings of -$0.15 per share, which would represent year-over-year growth of 44.44%. For the entire fiscal year, the Zacks Consensus Estimates are projecting earnings of -$0.18 per share and a revenue of $8.77 million, representing changes of +82.86% and 0%, respectively, from the prior year. It's also important for investors to be aware of any recent modifications to analyst estimates for Humacyte, Inc. These revisions help to show the ever-changing nature of near-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the business outlook. Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model. The Zacks Rank system, running from #1 (Strong Buy) to #5 (Strong Sell), holds an admirable track record of superior performance, independently audited, with #1 stocks contributing an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has remained steady. Humacyte, Inc. is holding a Zacks Rank of #2 (Buy) right now. The Medical - Biomedical and Genetics industry is part of the Medical sector. Currently, this industry holds a Zacks Industry Rank of 83, positioning it in the top 34% of all 250+ industries. The Zacks Industry Rank assesses the strength of our separate industry groups by calculating the average Zacks Rank of the individual stocks contained within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1. Remember to apply to follow these and more stock-moving metrics during the upcoming trading sessions. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Humacyte, Inc. (HUMA) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Business Insider
an hour ago
- Business Insider
A.P. Moeller Maersk A/S (0O77) Receives a Sell from Kepler Capital
In a report released on June 24, Axel Styrman from Kepler Capital maintained a Sell rating on A.P. Moeller Maersk A/S (0O77 – Research Report), with a price target of DKK9,250.00. The company's shares closed last Tuesday at DKK11,710.00. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Styrman covers the Energy sector, focusing on stocks such as Frontline, Euronav, and BW LPG Ltd. According to TipRanks, Styrman has an average return of -5.0% and a 37.10% success rate on recommended stocks. Currently, the analyst consensus on A.P. Moeller Maersk A/S is a Moderate Sell with an average price target of DKK10,500.00, which is a -10.33% downside from current levels. In a report released on June 19, Bernstein also maintained a Sell rating on the stock with a DKK9,350.00 price target.
